Anti-hyperglycemic evaluation of 2,4-thiazolidinedione and rhodanine derivatives | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Anti-hyperglycemic evaluation of 2,4-thiazolidinedione and rhodanine derivatives

Author(s): Archana Kapoor and Neha Khare

A novel series comprising of 10 derivatives of two chemical entities thiazolidinedione and rhodanine were synthesized and characterized physicochemically as well as by spectral means. The synthesized derivatives (THP, RHP, RHB, MB01-MB09) were then screened for anti-hyperglycemic activity in fructose-induced diabetic animal model. It can be concluded that presence of piperazine and N-methyl piperazine at N-3 of thiazolidinedione and rhodanine derivatives have shown significant activity in comparison to aromatic amine substitution. The presence of ether linkage is the primary requisite for anti-hyperglycemic activity. Condensation of benzylidene with lipophilic moiety i.e. benzothiazole enhanced the activity of the synthesized derivatives. Piperazine substituted compound, MB01was most potent anti-hyperglycemic activity that might be due to the availability of free nitrogen at receptor site.


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry